Abstract
Helicobacter pylori is a worldwide infection. In gastro-duodenal ulcer disease no doubt remains about the necessity of H. pylori eradication. Controversies subsisting in other pathologies such gastro-esophageal reflux, dyspepsia, gastritis, gastric adenocarcinoma or MALT lymphoma are reviewed. Multiple drug combinations have been proposed to cure the infection. These are discussed in the clinical setting of Belgian practice.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Dyspepsia / etiology
-
Dyspepsia / microbiology
-
Gastritis / etiology
-
Gastritis / microbiology
-
Gastroesophageal Reflux / etiology
-
Gastroesophageal Reflux / microbiology
-
Helicobacter Infections / complications*
-
Helicobacter Infections / pathology
-
Helicobacter pylori*
-
Humans
-
Lymphoma, B-Cell, Marginal Zone / etiology
-
Lymphoma, B-Cell, Marginal Zone / microbiology
-
Stomach Ulcer / etiology
-
Stomach Ulcer / microbiology*